T cell immunotherapy workflow improvements for clinical-grade manufacturing
Cell-based treatments are life-saving therapies with the potential to offer cures for cancers and other diseases.
Instrument-to-Instrument Variability: A hidden reason your protocol may not work in other labs
For many other types of measurement, close agreement between instruments is achieved by calibration to a reference standard. Some examples include the calibration of a group of analytical balances to a single reference mass and calibration of pH meters to a precisely prepared buffer solution.
Establishing a High-throughput Screening Platform for NK mediated Cytotoxicity using Image Cytometry
Researchers highlight the need for large-scale screening of cytotoxic cells and their ability to kill target cell lines in both a 2D and 3D fashion.
Webinar on Demand: Cell Counting Method Development for CAR-T Cell Therapy
Webinar on Demand: Accurate and consistent cell counting methods for development and manufacturing of CAR-T under GMP/GLP conditions.
Demo on Demand: Modern Cell-based Assays for Cell and Gene Therapy Using Image Cytometry
Watch the demo on demand: Modern Cell-based Assays for Cell and Gene Therapy Using Image Cytometry
Direct CAR NK Therapeutic Targeting for High-Risk Neuroblastoma
Detection of novel CD276-CAR NK-92 mediated cytotoxicity of neuroblastoma tumor spheroids using plate-based image cytometry
Webinar On-Demand: Cell Therapy Development for Solid Tumors
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Nexcelom’s CTO on the Future of CAR T Workflow
Nexcelom founder and CTO, Dr. Jean Qiu, describes 3 major reasons why we partner with global and local research organizations to streamline CAR-T workflow.
Advantages of a Standardized Automated Cell Counting Method for Cell Therapy
Q & A regarding the crucial need for accurate and consistent cell counting methods for development and manufacturing of CAR-T under GMP/GLP conditions.
Importance of Accuracy and Consistency for Viability and Concentration in the field of Adoptive Cell Transfer Therapy
What is adoptive cell transfer therapy? What cells are commonly used? What are the counting and viability methods for these cell types?
